Myomo (MYO) Tops Q2 EPS by 4c, provides guidance

Myomo (NYSE: MYO) reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $7.5 million versus the consensus estimate of $6.58 million.

GUIDANCE:

Myomo sees FY2024 revenue of $28-30 million, versus the consensus of $28.657 million.

For earnings history and earnings-related data on Myomo (MYO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
• FDA launches Operation TrialBlazer to accelerate drug research